Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
References<br />
1<br />
CDC. Treatment <strong>of</strong> latent tuberculosis infection: maximizing adherence. TB Fact Sheets [Division <strong>of</strong> <strong>Tuberculosis</strong><br />
Elimination Web site]. April 2005:1. Available at: http://www.cdc.gov/tb/pubs/TBfactsheets.htm . Accessed February 1,<br />
2007.<br />
2<br />
CDC. Chapter 5: treatment <strong>of</strong> Latent <strong>Tuberculosis</strong> Infection.. Core Curriculum on <strong>Tuberculosis</strong> (2004) [Division <strong>of</strong><br />
<strong>Tuberculosis</strong> Elimination Web site]. Updated October 2004. Available at:<br />
http://www.cdc.gov/tb/webcourses/CoreCurr/index.htm<br />
Accessed December 5, 2010.<br />
3<br />
ATS, CDC, IDSA. Controlling tuberculosis in the United <strong>State</strong>s: recommendations from the American Thoracic Society,<br />
CDC, and the Infectious Diseases Society <strong>of</strong> America. MMWR 2005;54(No. RR-12):15.<br />
4<br />
CDC. Treatment <strong>of</strong> latent tuberculosis infection: maximizing adherence. TB Fact Sheets [Division <strong>of</strong> <strong>Tuberculosis</strong><br />
Elimination Web site]. April 2005:1. Available at: http://www.cdc.gov/tb/pubs/TBfactsheets.htm . Accessed February 1,<br />
2007.<br />
5<br />
CDC. Treatment <strong>of</strong> latent tuberculosis infection: maximizing adherence. TB Fact Sheets [Division <strong>of</strong> <strong>Tuberculosis</strong><br />
Elimination Web site]. April 2005:1. Available at: http://www.cdc.gov/tb/pubs/TBfactsheets.htm . Accessed February 1,<br />
2007.<br />
6<br />
CDC. Chapter 5: treatment <strong>of</strong> Latent <strong>Tuberculosis</strong> Infection.. Core Curriculum on <strong>Tuberculosis</strong> (2004) [Division <strong>of</strong><br />
<strong>Tuberculosis</strong> Elimination Web site]. Updated October 2004. Available at:<br />
http://www.cdc.gov/tb/webcourses/CoreCurr/index.htm<br />
Accessed December 5, 2010.<br />
7<br />
CDC. Summary. In: Chapter 5: treatment <strong>of</strong> Latent <strong>Tuberculosis</strong> Infection.. Core Curriculum on <strong>Tuberculosis</strong> (2004)<br />
[Division <strong>of</strong> <strong>Tuberculosis</strong> Elimination Web site]. Updated October 2004. Available at:<br />
http://www.cdc.gov/tb/webcourses/CoreCurr/index.htm<br />
Accessed December 5, 2010.<br />
8 CDC . “Recommendations for Use <strong>of</strong> an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent<br />
Mycobacterium tuberculosis Infection. MMWR 2011; 60(48); 1650-1653. Available at:<br />
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6048a3.htm?s_cid=mm6048a3_w<br />
9<br />
ATS, CDC, IDSA. Controlling tuberculosis in the United <strong>State</strong>s: recommendations from the American Thoracic Society,<br />
CDC, and the Infectious Diseases Society <strong>of</strong> America. MMWR,2005;54(No. RR-12):39.<br />
10<br />
ATS, CDC, IDSA. Controlling tuberculosis in the United <strong>State</strong>s: recommendations from the American Thoracic<br />
Society, CDC, and the Infectious Diseases Society <strong>of</strong> America. MMWR 2005;54(No. RR-12):10.<br />
11<br />
CDC, NTCA. Guidelines for the investigation <strong>of</strong> contacts <strong>of</strong> persons with infectious tuberculosis: recommendations from<br />
the National <strong>Tuberculosis</strong> Controllers Association and CDC. MMWR 2005;54(No. RR-15):13.<br />
12<br />
CDC. In: Chapter 5: treatment <strong>of</strong> Latent <strong>Tuberculosis</strong> Infection.. Core Curriculum on <strong>Tuberculosis</strong> (2004) [Division <strong>of</strong><br />
<strong>Tuberculosis</strong> Elimination Web site]. Updated October 2004. Available at:<br />
http://www.cdc.gov/tb/webcourses/CoreCurr/index.htm<br />
Accessed December 5, 2010.<br />
13<br />
CDC, NTCA. Guidelines for preventing the transmission <strong>of</strong> Mycobacterium tuberculosis in health-care settings, 2005.<br />
MMWR 2005;54(No. RR-17):59; and CDC: Chapter 5: treatment <strong>of</strong> Latent <strong>Tuberculosis</strong> Infection.. Core Curriculum on<br />
<strong>Tuberculosis</strong> (2004) [Division <strong>of</strong> <strong>Tuberculosis</strong> Elimination Web site]. Updated October 2004. Available at:<br />
http://www.cdc.gov/tb/webcourses/CoreCurr/index.htm<br />
Accessed December 5, 2010.<br />
14<br />
CDC. Targeted tuberculin testing and treatment <strong>of</strong> latent tuberculosis infection. MMWR 2000;49(No. RR-6):27.<br />
15<br />
CDC. Targeted tuberculin testing and treatment <strong>of</strong> latent tuberculosis infection. MMWR 2000;49(No. RR-6):31, 36.<br />
16<br />
CDC. Targeted tuberculin testing and treatment <strong>of</strong> latent tuberculosis infection. MMWR 2000;49(No. RR-6):36.<br />
17 CDC . “Recommendations for Use <strong>of</strong> an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent<br />
Mycobacterium tuberculosis Infection. MMWR 2011; 60(48). Available at:<br />
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6048a3.htm?s_cid=mm6048a3_w<br />
18 CDC . “Recommendations for Use <strong>of</strong> an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent<br />
Mycobacterium tuberculosis Infection. MMWR 2011; 60(48); 1650-1653. Available at:<br />
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6048a3.htm?s_cid=mm6048a3_w<br />
19 ATS, CDC, IDSA. Treatment <strong>of</strong> tuberculosis. MMWR 2003;52(No. RR-11):4.<br />
20 CDC. Targeted tuberculin testing and treatment <strong>of</strong> latent tuberculosis infection. MMWR 2000;49(No. RR-6):28–29.<br />
21 CDC . “Recommendations for Use <strong>of</strong> an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent<br />
Mycobacterium tuberculosis Infection. MMWR 2011; 60(48); 1650-1653. Available at:<br />
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6048a3.htm?s_cid=mm6048a3_w<br />
22 Francis J. Curry National <strong>Tuberculosis</strong> Center. Pediatric <strong>Tuberculosis</strong>: An Online Presentation [Francis J. Curry National<br />
<strong>Tuberculosis</strong> Center Web site]. San Francisco, CA; 2007: Slides 59–60. Available at:<br />
http://currytbcenter.ucsf.edu/products/product_details.cfm?productID=ONL-10 . Accessed October 28, 2011.<br />
23 ATS, CDC, IDSA. Treatment <strong>of</strong> tuberculosis. MMWR 2003;52(No. RR-11):20.<br />
A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Treatment <strong>of</strong> Latent <strong>Tuberculosis</strong> Infection<br />
Revised November 2012<br />
8.26